Serveur d'exploration sur la maladie de Parkinson - Corpus (Accueil)

Index « ISSN » - entrée « 0001-6314 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
0001-6268 < 0001-6314 < 0001-6322  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 149.
[0-50] [0 - 20][0 - 50][50-70]
Ident.Authors (with country if any)Title
000174 (1991) S. W. Pedersen ; E. B Ckman ; B. ÖbergCharacteristics of tetanic muscle contraction in Parkinson patients
000232 (2008) I. Midi ; M. Dogan ; M. Koseoglu ; G. Can ; M. A. Sehitoglu ; D. I. GunalVoice abnormalities and their relation with motor dysfunction in Parkinson’s disease
000283 (1991) A. Lieberman ; E. FazziniExperience with selegiline and levodopa in advanced Parkinson's disease
000292 (1985) Charlotte Sachs ; Bo Berglund ; Lennart KaijserAutonomic cardiovascular responses in parkinsonism: effect of levodopa with dopa‐decarboxylase inhibition
000335 (1991) P. A. LewittDeprenyl's effect at slowing progression of parkinsonian disability: the DATATOP study
000339 (2003) M. Joebges ; M. Mrowka ; N. Schimke ; M. Shing ; R. Dengler ; P. OdinThree‐dimensional computerized analysis of diadochokinetic movements of Parkinsonian patients
000351 (2010) O. Tysnes ; B. Müller ; J. P. LarsenAre dysautonomic and sensory symptoms present in early Parkinson’s disease?
000364 (1991) S. W. Pederson ; T. Eriksson ; B. ÖbergEffects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient
000405 (1995) C. Trenkwalder ; W. Paulus ; S. Krafczyk ; M. Hawken ; W. H. Oertel ; Th. BrandtPostural stability differentiates “lower body” from idiopathic parkinsonism
000444 (2011) G-M. Hariz ; L. ForsgrenActivities of daily living and quality of life in persons with newly diagnosed Parkinson’s disease according to subtype of disease, and in comparison to healthy controls
000493 (1983) Reijo J. MarttilaDiagnosis and epidemiology of Parkinson's disease
000524 (2006) A. LiebermanDepression in Parkinson's disease – a review
000537 (2006) L. Ishihara ; C. BrayneA systematic review of depression and mental illness preceding Parkinson's disease
000562 (2006) A. E. Dias ; E. R. Barbosa ; K. Coracini ; F. Maia ; M. A. Marcolin ; F. FregniEffects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson's disease
000584 (1994) A. Morano ; F. J. Jiménez-Jiménez ; J. A. Molina ; M. A. AntolínRisk‐factors for Parkinson's disease: case‐control study in the province of Cáceres, Spain
000593 (1989) I. ShoulsonDeprenyl and tocopherol antioxidative therapy of parkinsonism (DATATOP)
000692 (2008) S. E. P Lhagen ; M. Carlsson ; E. Curman ; J. W Linder ; A. GranérusDepressive illness in Parkinson’s disease – indication of a more advanced and widespread neurodegenerative process?
000696 (2004) M. Białecka ; M. Dro Dzik ; G. Kłodowska-Duda ; K. Honczarenko ; B. Gawro Ska-Szklarz ; G. Opala ; J. StankiewiczThe effect of monoamine oxidase B (MAOB) and catechol‐O‐methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease
000708 (2005) S. Papapetropoulos ; A. Lieberman ; J. Gonzalez ; D. C. MashCan Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
000738 (2011) T. Archer ; A. Fredriksson ; B. JohanssonExercise alleviates Parkinsonism: clinical and laboratory evidence
000821 (1999) L. Battistin ; P. G. Bardin ; F. Ferro-Milone ; C. Ravenna ; V. Toso ; G. ReboldiAlpha‐dihydroergocryptine in Parkinson's disease: a multiceuntre randomized double blind parallel group study
000833 (2010) V. GundersenProtein aggregation in Parkinson’s disease
000874 (1994) V. Govoni ; E. Granieri ; M. R. Tola ; I. Casetta ; V. C. Monetti ; E. Fainardi ; E. PaolinoPrevalence of anti‐parkinson drugs’ use in Ferrara, Northern Italy, 1988
000931 (2006) A. M. Schlitter ; M. Kurz ; J. P. Larsen ; D. Woitalla ; T. Müller ; J. T. Epplen ; G. DekomienParkin gene variations in late‐onset Parkinson's disease: comparison between Norwegian and German cohorts
000978 (2002) J. FinstererParkinson syndrome as a manifestation of mitochondriopathy
000991 (1991) R. J. Marttila ; U. K. Rinne ; R. J. MarttilaProgression and survival in Parkinson's disease
000A18 (1976) Jes GerlachEFFECT of CB 154 (2‐BROMO‐ALPHA‐ERGOCRYPTINE) ON PARALYSIS AGITANS COMPARED WITH MADOPAR IN A DOUBLE‐BLIND, CROSS‐OVER TRIAL
000A60 (2008) B. Lilleeng ; E. DietrichsUnmasking psychiatric symptoms after STN deep brain stimulation in Parkinson’s disease
000A94 (1982) Raimo SulkavaAlzheimer's disease and senile dementia of Alzheimer type
000B62 (1990) M. Camerlingo ; B. Ferraro ; G. C. Gazzaniga ; L. Casto ; B. M. Cesana ; A. MamoliCardiovascular reflexes in Parkinson's disease: long‐term effects of levodopa treatment on de novo patients
000B75 (2005) M. Macht ; R. Schwarz ; H. EllgringPatterns of psychological problems in Parkinson's disease
000B83 (1989) R. J. Marttila ; U. K. RinneEpidemiological approaches to the etiology of Parkinson's disease
000B84 (2003) A. Albanese ; C. ColosimoDihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists
000C23 (2010) C. Vossius ; O. B. Nilsen ; J. P. LarsenParkinson’s disease and hospital admissions: frequencies, diagnoses and costs
000C46 (1998) R. Raschetti ; S. Spila-Alegiani ; N. Vanacore ; C. Ancona ; G. MecoMortality in a population‐based cohort of patients treated with antiparkinsonian drugs
000C57 (2001) S. Happe ; B. Schrödl ; M. Faltl ; C. Müller ; E. Auff ; J. ZeitlhoferSleep disorders and depression in patients with Parkinson's disease
000C58 (1983) P. Riederer ; K. JellingerNeurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline)
000C74 (1986) M. Hietanen ; H. Ter V InenCognitive performance in early Parkinson's disease
000C85 (2011) A. Kummer ; P. Scalzo ; F. Cardoso ; A. L. TeixeiraEvaluation of fatigue in Parkinson’s disease using the Brazilian version of Parkinson’s Fatigue Scale
000D53 (1989) A. Lieberman ; J. Ransohoff ; P. Berczeller ; P. Brous ; K. Eng ; M. Goldstein ; B. Kaufman ; M. Koslow ; L. ChinAdrenal medullary transplants as a treatment for advanced Parkinson's disease
000F11 (2006) B. Feldman ; J. Chapman ; A. D. KorczynApolipoprotein ɛ4 advances appearance of psychosis in patients with Parkinson's disease
000F48 (2010) K. Tanaka ; Y. Miyake ; W. Fukushima ; S. Sasaki ; C. Kiyohara ; Y. Tsuboi ; T. Yamada ; T. Oeda ; T. Miki ; N. Kawamura ; N. Sakae ; H. Fukuyama ; Y. Hirota ; M. NagaiActive and passive smoking and risk of Parkinson’s disease
000F80 (2007) A. Wallin ; S. Ekberg ; K. Lind ; V. Milos ; A. Granérus ; G. GranerusPosterior cortical brain dysfunction in cognitively impaired patients with Parkinson’s disease – a rCBF scintigraphy study
001008 (2008) K. Wada-Isoe ; K. Ohta ; K. Imamura ; M. Kitayama ; T. Nomura ; K. Yasui ; K. Nakaso ; K. NakashimaAssessment of hallucinations in Parkinson’s disease using a novel scale
001013 (1977) Reijo J. Marttila ; Urpo K. RinneDISABILITY AND PROGRESSION IN PARKINSON'S DISEASE
001030 (1994) J. P. Larsen ; E. Dupont ; E. TandbergClinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence
001148 (1995) M. A. Hely ; J. G. L. Morris ; W. G. J. Reid ; D. J. O'Sullivan ; P. M. Williamson ; G. A. Broe ; M. A. AdenaAge at onset: the major determinant of outcome in Parkinson's disease
001149 (2011) K. K. Johansen ; J. V. J Rgensen ; L. R. White ; M. J. Farrer ; J. O. AaslyParkinson‐related genetics in patients treated with deep brain stimulation
001261 (2005) K. Haugarvoll ; D. Aarsland ; T. Wentzel-Larsen ; J. P. LarsenThe influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease
001284 (2010) E. Wang ; Y. Sun ; J. Guo ; X. Gao ; J. Hu ; L. Zhou ; J. Hu ; C. JiangTetranectin and apolipoprotein A‐I in cerebrospinal fluid as potential biomarkers for Parkinson’s disease
001305 (1997) V. V. Myllyl ; K. A. Sotaniemi ; P. Hakulinen ; O. M Ki-Lkola ; E. H. HeinonenSelegiline as the primary treatment of Parkinson's disease — a long‐term double‐blind study

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i -k "0001-6314" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i  \
                -Sk "0001-6314" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0001-6314
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024